Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rosuvastatin as adjunctive therapy in acute exacerbation of COPD
IRCT2016121020024N4Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin in chronic obstructive pulmonary disease (COPD), sponsored by Tehran University of Medical Sciences. Started Jan 2017; status: completed.
02
Drugs
rosuvastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT2016121020024N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016121020024N4.